1
|
Weis SM and Cheresh DA: Tumor
angiogenesis: molecular pathways and therapeutic targets. Nat Med.
17:1359–1370. 2011. View
Article : Google Scholar : PubMed/NCBI
|
2
|
Lamalice L, Le Boeuf F and Huot J:
Endothelial cell migration during angiogenesis. Circ Res.
100:782–794. 2007. View Article : Google Scholar : PubMed/NCBI
|
3
|
Friedl P and Wolf K: Tumour-cell invasion
and migration: diversity and escape mechanisms. Nat Rev Cancer.
3:362–374. 2003. View
Article : Google Scholar : PubMed/NCBI
|
4
|
Baker EL and Zaman MH: The biomechanical
integrin. J Biomech. 43:38–44. 2010. View Article : Google Scholar :
|
5
|
Pasapera AM, Schneider IC, Rericha E,
Schlaepfer DD and Waterman CM: Myosin II activity regulates
vinculin recruitment to focal adhesions through FAK-mediated
paxillin phosphorylation. J Cell Biol. 188:877–890. 2010.
View Article : Google Scholar : PubMed/NCBI
|
6
|
Hsia DA, Mitra SK, Hauck CR, Streblow DN,
Nelson JA, Ilic D, Huang S, Li E, Nemerow GR, Leng J, et al:
Differential regulation of cell motility and invasion by FAK. J
Cell Biol. 160:753–767. 2003. View Article : Google Scholar : PubMed/NCBI
|
7
|
Thamilselvan V, Craig DH and Basson MD:
FAK association with multiple signal proteins mediates
pressure-induced colon cancer cell adhesion via a Src-dependent
PI3K/Akt pathway. FASEB J. 21:1730–1741. 2007. View Article : Google Scholar : PubMed/NCBI
|
8
|
Gurney SM, Forster P, Just U and
Schwanbeck R: Suppression of the PI3K subunit p85α delays embryoid
body development and inhibits cell adhesion. J Cell Biochem.
112:3573–3581. 2011. View Article : Google Scholar : PubMed/NCBI
|
9
|
Clark EA, King WG, Brugge JS, Symons M and
Hynes RO: Integrin-mediated signals regulated by members of the Rho
family of GTPases. J Cell Biol. 142:573–586. 1998. View Article : Google Scholar : PubMed/NCBI
|
10
|
Raftopoulou M and Hall A: Cell migration:
Rho GTPases lead the way. Dev Biol. 265:23–32. 2004. View Article : Google Scholar
|
11
|
Tavora B, Batista S, Reynolds LE, Jadeja
S, Robinson S, Kostourou V, Hart I, Fruttiger M, Parsons M and
Hodivala-Dilke KM: Endothelial FAK is required for tumour
angiogenesis. EMBO Mol Med. 2:516–528. 2010. View Article : Google Scholar : PubMed/NCBI
|
12
|
Zhao X and Guan JL: Focal adhesion kinase
and its signaling pathways in cell migration and angiogenesis. Adv
Drug Deliv Rev. 63:610–615. 2011. View Article : Google Scholar :
|
13
|
Yom CK, Noh DY, Kim WH and Kim HS:
Clinical significance of high focal adhesion kinase gene copy
number and overexpression in invasive breast cancer. Breast Cancer
Res Treat. 128:647–655. 2011. View Article : Google Scholar
|
14
|
Miyazaki T, Kato H, Nakajima M, Sohda M,
Fukai Y, Masuda N, Manda R, Fukuchi M, Tsukada K and Kuwano H: FAK
overexpression is correlated with tumour invasiveness and lymph
node metastasis in oesophageal squamous cell carcinoma. Br J
Cancer. 89:140–145. 2003. View Article : Google Scholar : PubMed/NCBI
|
15
|
Zhao J and Guan JL: Signal transduction by
focal adhesion kinase in cancer. Cancer Metastasis Rev. 28:35–49.
2009. View Article : Google Scholar : PubMed/NCBI
|
16
|
Wozniak MA, Modzelewska K, Kwong L and
Keely PJ: Focal adhesion regulation of cell behavior. Biochim
Biophys Acta. 1692:103–119. 2004. View Article : Google Scholar : PubMed/NCBI
|
17
|
Schlaepfer DD and Mitra SK: Multiple
connections link FAK to cell motility and invasion. Curr Opin Genet
Dev. 14:92–101. 2004. View Article : Google Scholar : PubMed/NCBI
|
18
|
Lu ZJ, Ren YQ, Wang GP, Song Q, Li M,
Jiang SS, Ning T, Guan YS, Yang JL and Luo F: Biological behaviors
and proteomics analysis of hybrid cell line EAhy926 and its parent
cell line A549. J Exp Clin Cancer Res. 28:162009. View Article : Google Scholar : PubMed/NCBI
|
19
|
Golubovskaya VM, Nyberg C, Zheng M, Kweh
F, Magis A, Ostrov D and Cance WG: A small molecule inhibitor,
1,2,4,5-benzenetetraamine tetrahydrochloride, targeting the y397
site of focal adhesion kinase decreases tumor growth. J Med Chem.
51:7405–7416. 2008. View Article : Google Scholar : PubMed/NCBI
|
20
|
Moissoglu K and Schwartz MA: Integrin
signalling in directed cell migration. Biol Cell. 98:547–555. 2006.
View Article : Google Scholar : PubMed/NCBI
|
21
|
Ezzell RM, Goldmann WH, Wang N,
Parashurama N and Ingber DE: Vinculin promotes cell spreading by
mechanically coupling integrins to the cytoskeleton. Exp Cell Res.
231:14–26. 1997. View Article : Google Scholar : PubMed/NCBI
|
22
|
Engelman JA: Targeting PI3K signalling in
cancer: opportunities, challenges and limitations. Nat Rev Cancer.
9:550–562. 2009. View Article : Google Scholar : PubMed/NCBI
|
23
|
Ridley AJ: Rho GTPases and actin dynamics
in membrane protrusions and vesicle trafficking. Trends Cell Biol.
16:522–529. 2006. View Article : Google Scholar : PubMed/NCBI
|
24
|
Schwarz J, Proff J, Hävemeier A, Ladwein
M, Rottner K, Barlag B, Pich A, Tatge H, Just I and Gerhard R:
Serine-71 phosphorylation of Rac1 modulates downstream signaling.
PLoS One. 7:e443582012. View Article : Google Scholar : PubMed/NCBI
|
25
|
Hoeben A, Landuyt B, Highley MS, Wildiers
H, Van Oosterom AT and De Bruijn EA: Vascular endothelial growth
factor and angiogenesis. Pharmacol Rev. 56:549–580. 2004.
View Article : Google Scholar : PubMed/NCBI
|
26
|
Unger RE, Krump-Konvalinkova V, Peters K
and Kirkpatrick CJ: In vitro expression of the endothelial
phenotype: comparative study of primary isolated cells and cell
lines, including the novel cell line HPMEC-ST1.6R. Microvasc Res.
64:384–397. 2002. View Article : Google Scholar : PubMed/NCBI
|
27
|
Sieg DJ, Hauck CR, Ilic D, Klingbeil CK,
Schaefer E, Damsky CH and Schlaepfer DD: FAK integrates
growth-factor and integrin signals to promote cell migration. Nat
Cell Biol. 2:249–256. 2000. View Article : Google Scholar : PubMed/NCBI
|
28
|
Braren R, Hu H, Kim YH, Beggs HE,
Reichardt LF and Wang R: Endothelial FAK is essential for vascular
network stability, cell survival, and lamellipodial formation. J
Cell Biol. 172:151–162. 2006. View Article : Google Scholar : PubMed/NCBI
|
29
|
van Nimwegen MJ, Verkoeijen S, van Buren
L, Burg D and van de Water B: Requirement for focal adhesion kinase
in the early phase of mammary adenocarcinoma lung metastasis
formation. Cancer Res. 65:4698–4706. 2005. View Article : Google Scholar : PubMed/NCBI
|
30
|
McLean GW, Carragher NO, Avizienyte E,
Evans J, Brunton VG and Frame MC: The role of focal-adhesion kinase
in cancer - a new therapeutic opportunity. Nat Rev Cancer.
5:505–515. 2005. View Article : Google Scholar : PubMed/NCBI
|
31
|
Beierle EA, Ma X, Stewart J, Nyberg C,
Trujillo A, Cance WG and Golubovskaya VM: Inhibition of focal
adhesion kinase decreases tumor growth in human neuroblastoma. Cell
Cycle. 9:1005–1015. 2010. View Article : Google Scholar : PubMed/NCBI
|
32
|
Hochwald SN, Nyberg C, Zheng M, Zheng D,
Wood C, Massoll NA, Magis A, Ostrov D, Cance WG and Golubovskaya
VM: A novel small molecule inhibitor of FAK decreases growth of
human pancreatic cancer. Cell Cycle. 8:2435–2443. 2009. View Article : Google Scholar : PubMed/NCBI
|
33
|
Infusino GA and Jacobson JR: Endothelial
FAK as a therapeutic target in disease. Microvasc Res. 83:89–96.
2012. View Article : Google Scholar
|
34
|
Golubovskaya VM and Cance W: Focal
adhesion kinase and p53 signal transduction pathways in cancer.
Front Biosci (Landmark Ed). 15:901–912. 2010. View Article : Google Scholar
|
35
|
Lim ST, Mikolon D, Stupack DG and
Schlaepfer DD: FERM control of FAK function: implications for
cancer therapy. Cell Cycle. 7:2306–2314. 2008. View Article : Google Scholar : PubMed/NCBI
|
36
|
Eleniste PP and Bruzzaniti A: Focal
adhesion kinases in adhesion structures and disease. J Signal
Transduct. 2012:2964502012. View Article : Google Scholar : PubMed/NCBI
|
37
|
Zheng Y and Lu Z: Paradoxical roles of FAK
in tumor cell migration and metastasis. Cell Cycle. 8:3474–3479.
2009. View Article : Google Scholar : PubMed/NCBI
|
38
|
Yano H, Mazaki Y, Kurokawa K, Hanks SK,
Matsuda M and Sabe H: Roles played by a subset of integrin
signaling molecules in cadherin-based cell-cell adhesion. J Cell
Biol. 166:283–295. 2004. View Article : Google Scholar : PubMed/NCBI
|
39
|
Hauck CR, Sieg DJ, Hsia DA, Loftus JC,
Gaarde WA, Monia BP and Schlaepfer DD: Inhibition of focal adhesion
kinase expression or activity disrupts epidermal growth
factor-stimulated signaling promoting the migration of invasive
human carcinoma cells. Cancer Res. 61:7079–7090. 2001.PubMed/NCBI
|
40
|
Lu Z, Jiang G, Blume-Jensen P and Hunter
T: Epidermal growth factor-induced tumor cell invasion and
metastasis initiated by dephosphorylation and downregulation of
focal adhesion kinase. Mol Cell Biol. 21:4016–4031. 2001.
View Article : Google Scholar : PubMed/NCBI
|
41
|
Cicchini C, Laudadio I, Citarella F,
Corazzari M, Steindler C, Conigliaro A, Fantoni A, Amicone L and
Tripodi M: TGFbeta-induced EMT requires focal adhesion kinase (FAK)
signaling. Exp Cell Res. 314:143–152. 2008. View Article : Google Scholar
|
42
|
Kallergi G, Agelaki S, Markomanolaki H,
Georgoulias V and Stournaras C: Activation of FAK/PI3K/Rac1
signaling controls actin reorganization and inhibits cell motility
in human cancer cells. Cell Physiol Biochem. 20:977–986. 2007.
View Article : Google Scholar : PubMed/NCBI
|
43
|
Tadokoro S, Shattil SJ, Eto K, Tai V,
Liddington RC, de Pereda JM, Ginsberg MH and Calderwood DA: Talin
binding to integrin beta tails: a final common step in integrin
activation. Science. 302:103–106. 2003. View Article : Google Scholar : PubMed/NCBI
|
44
|
Baumann K: Cell adhesion: FAK or talin:
who goes first. Nat Rev Mol Cell Biol. 13:138–139. 2012.
|
45
|
Zaidel-Bar R, Milo R, Kam Z and Geiger B:
A paxillin tyrosine phosphorylation switch regulates the assembly
and form of cell-matrix adhesions. J Cell Sci. 120:137–148. 2007.
View Article : Google Scholar
|
46
|
Lawson C, Lim ST, Uryu S, Chen XL,
Calderwood DA and Schlaepfer DD: FAK promotes recruitment of talin
to nascent adhesions to control cell motility. J Cell Biol.
196:223–232. 2012. View Article : Google Scholar : PubMed/NCBI
|
47
|
Weis SM, Lim ST, Lutu-Fuga KM, Barnes LA,
Chen XL, Göthert JR, Shen TL, Guan JL, Schlaepfer DD and Cheresh
DA: Compensatory role for Pyk2 during angiogenesis in adult mice
lacking endothelial cell FAK. J Cell Biol. 181:43–50. 2008.
View Article : Google Scholar : PubMed/NCBI
|
48
|
Lim Y, Lim ST, Tomar A, Gardel M,
Bernard-Trifilo JA, Chen XL, Uryu SA, Canete-Soler R, Zhai J, Lin
H, et al: PyK2 and FAK connections to p190Rho guanine nucleotide
exchange factor regulate RhoA activity, focal adhesion formation,
and cell motility. J Cell Biol. 180:187–203. 2008. View Article : Google Scholar : PubMed/NCBI
|
49
|
Schaller MD: Paxillin: a focal
adhesion-associated adaptor protein. Oncogene. 20:6459–6472. 2001.
View Article : Google Scholar : PubMed/NCBI
|
50
|
Xia H, Nho RS, Kahm J, Kleidon J and Henke
CA: Focal adhesion kinase is upstream of phosphatidylinositol
3-kinase/Akt in regulating fibroblast survival in response to
contraction of type I collagen matrices via a beta 1 integrin
viability signaling pathway. J Biol Chem. 279:33024–33034. 2004.
View Article : Google Scholar : PubMed/NCBI
|
51
|
Reiske HR, Kao SC, Cary LA, Guan JL, Lai
JF and Chen HC: Requirement of phosphatidylinositol 3-kinase in
focal adhesion kinase-promoted cell migration. J Biol Chem.
274:12361–12366. 1999. View Article : Google Scholar : PubMed/NCBI
|
52
|
Myers JP, Robles E, Ducharme-Smith A and
Gomez TM: Focal adhesion kinase modulates Cdc42 activity downstream
of positive and negative axon guidance cues. J Cell Sci.
125:2918–2929. 2012. View Article : Google Scholar : PubMed/NCBI
|
53
|
Ren XD, Kiosses WB, Sieg DJ, Otey CA,
Schlaepfer DD and Schwartz MA: Focal adhesion kinase suppresses Rho
activity to promote focal adhesion turnover. J Cell Sci.
113:3673–3678. 2000.PubMed/NCBI
|